Discovery of {4-[4,9-bis(ethyloxy)-1-oxo-1,3-dihydro-2H-benzo[f]isoindol-2-yl]-2-fluorophenyl}acetic acid (GSK726701A), a novel EP4 receptor partial agonist for the treatment of pain
A novel series of EP4 agonists and antagonists have been identified, and then used to validate their potential in the treatment of inflammatory pain. This paper describes these novel ligands and their activity within a number of pre-clinical mo
Healy, Mark P.,Allan, Amanda C.,Bailey, Kristin,Billinton, Andy,Chessell, Iain P.,Clayton, Nicholas M.,Giblin, Gerard M.P.,Kay, Melanie A.,Khaznadar, Tarik,Michel, Anton D.,Naylor, Alan,Price, Helen,Spalding, David J.,Stevens, David A.,Swarbrick, Martin E.,Wilson, Alexander W.
p. 1892 - 1896
(2018/05/17)
ISOINDOL DERIVATIVES AS EP4 RECEPTOR AGONISTS
The present invention relates to indole derivatives, to processes for their preparation, to pharmaceutical compositions containing them and to their use in medicine.
-
Page/Page column 26
(2008/12/05)
More Articles about upstream products of 1021167-95-2